Chronic Kidney Disease Improvement in Research and Treatment Act of 2024
Latest Action
Read twice and referred to the Committee on Finance.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Chronic Kidney Disease Improvement in Research and Treatment Act of 2024 (S.4469) is a Senate bill introduced in the 118th Congress aimed at enhancing research and treatment efforts related to chronic kidney disease. The bill was read twice and referred to the Senate Committee on Finance but ultimately failed or expired without further action. No official summary or full text is available, limiting detailed analysis of its provisions. The bill falls under the health policy area and presumably sought to improve outcomes for individuals affected by chronic kidney disease through federal initiatives.
S.4469 intended to address chronic kidney disease through improved research and treatment but did not advance beyond committee referral and expired in the 118th Congress.
- The bill was introduced in the Senate during the 118th Congress and referred to the Committee on Finance.
- Its focus is on chronic kidney disease, a significant public health issue.
- No official summary or full text is publicly available, restricting detailed content analysis.
['Individuals living with chronic kidney disease', 'Healthcare providers specializing in kidney disease', 'Research institutions focused on kidney health', 'Federal health agencies involved in disease research and treatment']
['Lack of publicly available full text and summary limits transparency and understanding of specific provisions.', 'Unclear funding mechanisms and authority for implementation due to missing bill text.', 'Potential challenges in oversight and enforcement cannot be assessed without detailed provisions.']
The bill was introduced in the Senate and referred to the Committee on Finance during the 118th Congress. It did not progress beyond committee referral and was classified as failed or expired. The absence of detailed legislative text or summary suggests limited legislative momentum or prioritization within the 118th Congress.
Hidden impact flags detected: 1
GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['If enacted, the bill could have led to increased federal funding and focus on chronic kidney disease research, potentially influencing healthcare practices and patient outcomes.', 'Enhanced research initiatives might stimulate innovation in treatment options and improve disease management protocols.', 'Federal agency priorities and resource allocations in health research could shift toward kidney disease.']
The absence of an official summary and full bill text restricts comprehensive transparency and public oversight. Tracking the bill's referral to the Committee on Finance without further action highlights the importance of monitoring committee activities and legislative progress to understand policy developments. Future transparency efforts would benefit from ensuring full documentation is publicly accessible to allow informed analysis.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.